Ex vivo expansion of cord blood
- PMID: 19802023
- PMCID: PMC4157906
- DOI: 10.1038/bmt.2009.284
Ex vivo expansion of cord blood
Abstract
A marked increase in the utilization of umbilical cord blood (UCB) transplantation has been observed in recent years; however, the use of UCB as a hematopoietic stem cell (HSC) source is limited primarily by the number of progenitor cells contained in the graft. Graft failure, delayed engraftment and profound delay in immune reconstitution lead to significant morbidity and mortality in adults. The lack of cells available for post transplant therapies, such as donor lymphocyte infusions, has also been considered to be a disadvantage of UCB. To improve outcomes and extend applicability of UCB transplantation, one potential solution is ex vivo expansion of UCB. Investigators have used several methods, including liquid suspension culture with various cytokines and expansion factors, co-culture with stromal elements and continuous perfusion systems. Techniques combining ex vivo expanded and unmanipulated UCB are being explored to optimize the initial engraftment kinetics as well as the long-term durability. The optimal expansion conditions are still not known; however, recent studies suggest that expanded UCB is safe. It is hoped that by ex vivo expansion of UCB, a resulting decrease in the morbidity and mortality of UCB transplantation will be observed, and that the availability of additional cells may allow adoptive immunotherapy or gene transfer therapies in the UCB setting.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Cohen Y, Kreiser D, Mayorov M, Nagler A. Unrelated and related cord blood banking and hematopoietic graft engineering. Cell Tissue Bank. 2003;4:29–35. - PubMed
-
- Cohen Y, Nagler A. Umbilical cord blood transplantation–how, when and for whom? Blood Rev. 2004;18:167–179. - PubMed
-
- Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157–166. - PubMed
-
- Broxmeyer HE, Gluckman E, Auerbach A, Douglas GW, Friedman H, Cooper S, et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/ progenitor cells. Int J Cell Cloning. 1990;8(Suppl 1):76–89. discussion 89–91. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical